Hydroxyzine dihydrochloride

CAS: 2192-20-3

Ref. 3D-FH24516

Produktinformation

• Name: Hydroxyzine dihydrochloride
• Synonyme: 2-[2-[4-[(4-Chlorophenyl)-phenylmethyl]-1-piperazinyl]ethoxy]ethanol dihydrochlorideAlamonAtarax, 1-(p-Chlorobenzhydryl)-4-[2-(2-hydroxyethoxy)ethyl]diethylenediamine dihydrochloride, 2-(2-{4-[(4-Chlorophenyl)(Phenyl)Methyl]Piperazin-1-Yl}Ethoxy)Ethanol Dihydrochloride, 2-[2-[4-(p-Chloro-α-phenylbenzyl)-1-piperazinyl]ethoxy]ethanol dihydrochloride, 2-[2-[4-[(4-Chlorophenyl)Phenymethyl]-1-Piperazinyl]Ethoxy]Ethanol Dihydrochloride, Alamon, Atarax, Atarax P Parenteral soln., Atarax dihydrochloride, Aterax, Atranine A, Durrax, Ethanol, 2-[2-[4-(p-chloro-α-phenylbenzyl)-1-piperazinyl]ethoxy]-, dihydrochloride, Ethanol, 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-, hydrochloride (1:2), Ethanol,2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-, dihydrochloride,(+)-, Hydroxizine chloride, Hydroxyzine Di Hcl, Hydroxyzine hcl, Hydroxyzine hydrochloride, Hydroxyzyne hydrochloride, Neurolax, Orgatrax, Quiess, Vistaril Parenteral, Vistaril Steraject

Beschreibung

Hydroxyzine is an antihistamine drug that produces its therapeutic effects by blocking the action of histamine - a chemical involved in allergic reactions. This medication also has a sedative effect and can be used to treat anxiety disorders. Hydroxyzine has been shown to block the physiological effects of adrenaline, which may lead to its use as a treatment for allergies. It has also been shown to inhibit skin tests in humans when administered at a dose of 25-50mg/kg. Hydroxyzine pamoate is an ester prodrug of hydroxyzine with improved absorption and distribution after oral administration. The most common symptoms associated with this drug are itching, hives, and swelling. Idiopathic urticaria is a type of urticaria (hives) that is not caused by an allergy or another underlying medical condition.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 447.83 g/mol
• Formel: C₂₁H₂₉Cl₃N₂O₂
• Reinheit: Min. 95%